Our data demonstrate that specific Env variants sampled during SHIV.5MUT infection successfully elicit diverse V3-glycan bNAbs with multiple, distinct immunogenetic and structural solutions to epitope engagement. The gene discussed is ERVW-1; the disease is infection.